Development and validation of a prediction model for adenoma detection during screening and surveillance colonoscopy with comparison to actual adenoma detection rates.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28957445)

Published in PLoS One on September 28, 2017

Authors

Eelco C Brand1,2, Julia E Crook3, Colleen S Thomas3, Peter D Siersema4, Douglas K Rex5, Michael B Wallace1

Author Affiliations

1: Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States of America.
2: Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands.
3: Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, Florida, United States of America.
4: Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
5: Department of Gastroenterology and Hepatology, Indiana University Medical Center, Indianapolis, Indiana, United States of America.

Articles cited by this

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ (2009) 19.23

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med (2012) 16.55

Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 11.76

Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol (2006) 7.83

Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72

Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54

Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol (2006) 6.03

Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med (2015) 4.32

Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Ann Intern Med (2015) 3.45

An endoscopic quality improvement program improves detection of colorectal adenomas. Am J Gastroenterol (2013) 3.38

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol (2012) 3.37

Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut (2013) 2.50

Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol (2013) 2.30

Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol (2003) 2.12

Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06

Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program. Gastroenterology (2015) 1.95

Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet (2003) 1.95

A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut (2014) 1.83

The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut (2011) 1.48

Risk of Advanced Adenomas in Siblings of Individuals With Advanced Adenomas: A Cross-Sectional Study. Gastroenterology (2015) 1.42

Leadership training to improve adenoma detection rate in screening colonoscopy: a randomised trial. Gut (2015) 1.16

A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut (2013) 1.10

Adenoma detection rate increases with each decade of life after 50 years of age. Gastrointest Endosc (2011) 1.07

Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology (2006) 1.07

Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol (2012) 1.02

Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial. JAMA Intern Med (2016) 0.96

The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy. BMC Gastroenterol (2011) 0.91

A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy. Am J Gastroenterol (2015) 0.87

Systematic review with meta-analysis: alcohol consumption and the risk of colorectal adenoma. Aliment Pharmacol Ther (2014) 0.87

Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals. Eur J Gastroenterol Hepatol (2011) 0.86

Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol (2014) 0.86

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy (2017) 0.86

Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea. J Clin Gastroenterol (2015) 0.86

The impact of exclusion criteria on a physician's adenoma detection rate. Gastrointest Endosc (2015) 0.84

Internal validation of risk models in clustered data: a comparison of bootstrap schemes. Am J Epidemiol (2013) 0.78

Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions. Am J Gastroenterol (2016) 0.78

Effect of an endoscopic quality improvement program on adenoma detection rates: A multicenter cluster-randomized controlled trial in a clinical practice setting (EQUIP-3). Gastrointest Endosc (2016) 0.77

Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy. Cancer Epidemiol Biomarkers Prev (2015) 0.77

Strategies to Increase Adenoma Detection Rates. Curr Treat Options Gastroenterol (2017) 0.77